Abstract
The first recognised outbreak of Marburg virus disease in Africa, and the first since the original epidemic in West Germany and Yugoslavia in 1967, occurred in South Africa in February 1975. The primary case was in a young Australian man , who was admitted to the Johannesburg Hospital after having toured Rhodesia. Two secondary cases occurred, one being in the first patient's travelling companion, and the other in a nurse. Features of the illness included high fever, myalgia, vomiting and diarrhoea, hepatitis, a characteristic maculopapular rash, leucopenia, thrombocytopenia, and a bleeding tendency. The first patient died on the seventh day from haemorrhage resulting from a combination of disseminated intravascular coagulation and hepatic failure. The other two patients were given vigorous supportive treatment and prophylactic heparin and recovered after an acute phase lasting about seven days. During this period on developed pancreatitis, the serum amylase remaining raised until the 32nd day after the onset of the illness. The other developed unilateral uveitis after having been asymptomatic for two months. This persisted for several weeks and Marburg virus was cultured from the anterior chamber of the eye.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abildgaard C. F. Recognition and treatment of intravascular coagulation. J Pediatr. 1969 Feb;74(2):163–176. doi: 10.1016/s0022-3476(69)80064-8. [DOI] [PubMed] [Google Scholar]
- Corrigan J. J., Jr, Jordan C. M. Heparin therapy in septicemia with disseminated intravascular coagulation. N Engl J Med. 1970 Oct 8;283(15):778–782. doi: 10.1056/NEJM197010082831502. [DOI] [PubMed] [Google Scholar]
- ELLIS B. C., STRANSKY A. A quick and accurate method for the determination of fibronogen in plasma. J Lab Clin Med. 1961 Sep;58:477–488. [PubMed] [Google Scholar]
- Katz J., Lurie A., Kaplan B. Haemolytic-uraemic syndrome and heparin therapy. Lancet. 1969 Sep 27;2(7622):700–700. doi: 10.1016/s0140-6736(69)90416-4. [DOI] [PubMed] [Google Scholar]
- Martini G. A. Marburg agent disease: in man. Trans R Soc Trop Med Hyg. 1969;63(3):295–302. doi: 10.1016/0035-9203(69)90001-7. [DOI] [PubMed] [Google Scholar]
- McKay D. G., Margaretten W. Disseminated intravascular coagulation in virus diseases. Arch Intern Med. 1967 Aug;120(2):129–152. [PubMed] [Google Scholar]
- Monath T. P. Lassa fever and Marburg virus disease. WHO Chron. 1974 May;28(5):212–219. [PubMed] [Google Scholar]
- Murphy F. A., Simpson D. I., Whitfield S. G., Zlotnik I., Carter G. B. Marburg virus infection in monkeys. Ultrastructural studies. Lab Invest. 1971 Apr;24(4):279–291. [PubMed] [Google Scholar]
- Regoeczi E. Iodine-labelled fibrinogen: a review. Br J Haematol. 1971 Jun;20(6):649–663. doi: 10.1111/j.1365-2141.1971.tb00804.x. [DOI] [PubMed] [Google Scholar]
- Siegert R. The Marburg virus (vervet monkey agent). Mod Trends Med Virol. 1970;2(0):204–240. [PubMed] [Google Scholar]